🌎 Pfizer Initiated, GSK Downgraded, Moderna Initiated and more…

RJ Hamster

5 hours ago

Ratings changes for Intuitive Machines, Applied Materials, AST SpaceMobile, Moderna, Enphase Energy, bluebird bio, Powell Industries and more…Text “MarketBeat” to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.

Unsubscribe.

VIEW MY PORTFOLIO

NOVEMBER 15TH, 2024

JD Vance’s Shocking Warning: Your Money’s Next. (ad)

Kamala’s Last-Ditch Move: Digital Dollar Control BEFORE Trump Takes Office!

GO HERE TO SEE WHY MOVING YOUR MONEY MIGHT BE YOUR ONLY WAY OUT.

Today’s Top Stories

Top-Performing Non-Leveraged ETFs This Year

BY NATHAN REIFF | NOVEMBER 15, 2024 08:01 AM

TRUMP WON: Buy gold NOW? (Ad)

BY GOLDCO PRECIOUS METALS

U.S. protectionism could undermine modest growth forecast for eurozone, says EU Commission

BY THE ASSOCIATED PRESS | NOVEMBER 15, 2024 06:50 AM

Rivian’s Wild Ride: Is the Dip a Buying Opportunity?

BY JEFFREY NEAL JOHNSON | NOVEMBER 15, 2024 07:30 AM

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

BY CRYPTO SWAP PROFITS

UK Treasury chief says she’s not satisfied by paltry third-quarter economic growth

BY THE ASSOCIATED PRESS | NOVEMBER 15, 2024 01:38 AM

Freshworks Stock Soars 50% – Is This the Perfect Entry Point?

BY SAM QUIRKE | NOVEMBER 15, 2024 06:47 AM

Quick Links

MarketBeat All Access

Morals and money… dollars and democracy (ad)

If you missed it, my emergency election broadcast is now available – but will be removed soon

CLICK HERE TO WATCH IT NOW.

Your Watchlist

MANAGE YOUR WATCHLIST AND MONITOR YOUR PORTFOLIO

Apple Inc. (AAPL)

(11/15) How To Earn $500 A Month From Apple Stock (benzinga.com)
(11/15) Magnificent 7 Are Alive And Well, But A Rest Is Inevitable (seekingalpha.com)
(11/15) Apple Q4 Earnings Transcript (marketbeat.com)
(11/15) Meet the Supercharged Growth Stock Headed to $4 Trillion Over the Coming 12 to 18 Months, According to 1 Wall Street Analyst (Hint: Not Nvidia) (fool.com)
(11/15) Driehaus Capital Management LLC Acquires 11,949 Shares of Apple Inc. (NASDAQ:AAPL)(marketbeat.com)

Amazon.com, Inc. (AMZN)

(11/15) Ambani’s Reliance asks India to review reach of Musk’s Starlink, Amazon (reuters.com)
(11/15) Here’s what Cathie Wood is buying as she sells off Tesla shares (finbold.com)
(11/15) Hims & Hers stock tanks as Amazon debuts fixed pricing for hair-loss and erectile-dysfunction drugs(fastcompany.com)
(11/15) Amazon.com Q3 Earnings Transcript (marketbeat.com)
(11/15) Amazon Has a Secret Weapon That’s Driving a Surge in Sales (fool.com)

Alphabet Inc. (GOOGL)

(11/15) Investors Heavily Search Alphabet Inc. (GOOGL): Here is What You Need to Know (zacks.com)
(11/15) Google tests removing news articles from search in EU, but it’s already backfiring (techcrunch.com)
(11/15) Alphabet Q3 Earnings Transcript (marketbeat.com)
(11/15) Got $200? 2 Top Growth Stocks to Buy That Could Double Your Money (fool.com)
(11/15) Realta Investment Advisors Decreases Stock Holdings in Alphabet Inc. (NASDAQ:GOOGL)(marketbeat.com)

Meta Platforms, Inc. (META)

Microsoft Co. (MSFT)

(11/15) Microsoft Corporation (MSFT) Fell on Concerns Over Data Centre Sustainability (msn.com)
(11/15) Musk Ramps Up Legal Fight With OpenAI, Microsoft (wsj.com)
(11/15) Elon Musk adds Microsoft as a defendant in OpenAI lawsuit, accusing them of anticompetitive conduct(businessinsider.com)
(11/15) Microsoft Q1 Earnings Transcript (marketbeat.com)
(11/15) Microsoft brought back this feature to the new version of Outlook (msn.com)

MANAGE YOUR WATCHLIST

Analysts’ Upgrades

Autolus Therapeutics (NASDAQ:AUTL) was upgraded by analysts at Redburn Atlantic from a “neutral” rating to a “buy” rating. They now have a $13.00 price target on the stock. This represents a 334.8% upside from the current price of $2.99.

Bloom Energy (NYSE:BE) was upgraded by analysts at Piper Sandler from a “neutral” rating to an “overweight” rating. They now have a $20.00 price target on the stock, up previously from $10.00. This represents a 1.7% upside from the current price of $19.66.

BrightView (NYSE:BV) was upgraded by analysts at William Blair from a “market perform” rating to an “outperform” rating.The current price is $15.92.

Comerica (NYSE:CMA) was upgraded by analysts at Wells Fargo & Company from an “underweight” rating to an “equal weight” rating. They now have a $73.00 price target on the stock, up previously from $51.00. This represents a 5.1% upside from the current price of $69.44.

The Descartes Systems Group (NASDAQ:DSGX) (TSE:DSG) was upgraded by analysts at Barclays PLC from an “underweight” rating to an “equal weight” rating. They now have a $125.00 price target on the stock, up previously from $88.00. This represents a 12.7% upside from the current price of $110.93.

Hanmi Financial (NASDAQ:HAFC) was upgraded by analysts at Janney Montgomery Scott from a “neutral” rating to a “buy” rating.The current price is $25.51.

InterContinental Hotels Group (NYSE:IHG) was upgraded by analysts at Barclays PLC from an “equal weight” rating to an “overweight” rating.The current price is $121.72.

Independence Realty Trust (NYSE:IRT) was upgraded by analysts at BMO Capital Markets from an “underperform” rating to a “market perform” rating. They now have a $21.00 price target on the stock, up previously from $19.00. This represents a 0.0% upside from the current price of $20.99.

Kulicke and Soffa Industries (NASDAQ:KLIC) was upgraded by analysts at Needham & Company LLC from a “hold” rating to a “buy” rating. They now have a $55.00 price target on the stock. This represents a 17.3% upside from the current price of $46.90.

Morgan Stanley (NYSE:MS) was upgraded by analysts at Wells Fargo & Company from an “underweight” rating to an “equal weight” rating. They now have a $142.00 price target on the stock, up previously from $107.00. This represents a 6.3% upside from the current price of $133.60.

Sally Beauty (NYSE:SBH) was upgraded by analysts at Raymond James from an “underperform” rating to a “market perform” rating.The current price is $13.24.

Twilio (NYSE:TWLO) was upgraded by analysts at Monness Crespi & Hardt from a “neutral” rating to a “buy” rating. They now have a $135.00 price target on the stock. This represents a 39.2% upside from the current price of $97.00.

UGI (NYSE:UGI) was upgraded by analysts at Mizuho from a “neutral” rating to an “outperform” rating. They now have a $30.00 price target on the stock, up previously from $27.00. This represents a 24.0% upside from the current price of $24.20.

VIEW MORE UPGRADES

Bill Gates’s Next Big AI Bet: Stargate (ad)

In February 2016… when almost nobody was talking about artificial intelligence….

I picked Nvidia as one of my favorite stocks.

Shares have jumped by more than 20,000% since then.

I BELIEVE WE ARE ABOUT TO DO IT AGAIN WITH THIS NEW AI PROJECT CALLED STARGATE

Analysts’ Downgrades

Akoya Biosciences (NASDAQ:AKYA) was downgraded by analysts at Craig Hallum from a “buy” rating to a “hold” rating. They now have a $5.00 price target on the stock, down previously from $7.00. This represents a 99.2% upside from the current price of $2.51.

Digital Turbine (NASDAQ:APPS) was downgraded by analysts at Bank of America Co. from a “neutral” rating to an “underperform” rating. They now have a $1.00 price target on the stock. This represents a 28.8% downside from the current price of $1.41.

Alexandria Real Estate Equities (NYSE:ARE) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a “buy” rating to a “hold” rating. They now have a $112.00 price target on the stock, down previously from $135.00. This represents a 6.5% upside from the current price of $105.15.

bluebird bio (NASDAQ:BLUE) was downgraded by analysts at Bank of America Co. from a “buy” rating to a “neutral” rating. They now have a $0.50 price target on the stock, down previously from $3.00. This represents a 53.0% upside from the current price of $0.33.

bluebird bio (NASDAQ:BLUE) was downgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “underweight” rating.The current price is $0.33.

Bionano Genomics (NASDAQ:BNGO) was downgraded by analysts at LADENBURG THALM/SH SH from a “buy” rating to a “neutral” rating.The current price is $0.24.

Compass Therapeutics (NASDAQ:CMPX) was downgraded by analysts at Leerink Partners from an “outperform” rating to a “market perform” rating. They now have a $4.00 price target on the stock, down previously from $5.00. This represents a 178.7% upside from the current price of $1.44.

DiamondRock Hospitality (NYSE:DRH) was downgraded by analysts at Evercore ISI from an “outperform” rating to an “inline” rating. They now have a $10.50 price target on the stock. This represents a 17.8% upside from the current price of $8.91.

GSK (NYSE:GSK) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a “buy” rating to a “hold” rating.The current price is $33.35.

Landstar System (NASDAQ:LSTR) was downgraded by analysts at Raymond James from an “outperform” rating to a “market perform” rating.The current price is $182.81.

NICE (NASDAQ:NICE) was downgraded by analysts at Oppenheimer Holdings Inc. from an “outperform” rating to a “market perform” rating.The current price is $178.71.

Grupo Aeroportuario del Centro Norte (NASDAQ:OMAB) was downgraded by analysts at Bank of America Co. from a “buy” rating to an “underperform” rating. They now have a $71.50 price target on the stock. This represents a 11.5% upside from the current price of $64.12.

Omega Therapeutics (NASDAQ:OMGA) was downgraded by analysts at Raymond James from an “outperform” rating to a “market perform” rating.The current price is $0.83.

Royal Bank of Canada (NYSE:RY) (TSE:RY) was downgraded by analysts at TD Securities from a “buy” rating to a “hold” rating.The current price is $121.13.

Sachem Capital (NYSEAMERICAN:SACH) was downgraded by analysts at Alliance Global Partners from a “buy” rating to a “neutral” rating.The current price is $1.79.

Sow Good (NASDAQ:SOWG) was downgraded by analysts at Roth Mkm from a “buy” rating to a “neutral” rating. They now have a $4.00 price target on the stock, down previously from $17.00. This represents a 3.1% upside from the current price of $3.88.

Sow Good (NASDAQ:SOWG) was downgraded by analysts at Craig Hallum from a “buy” rating to a “hold” rating. They now have a $4.50 price target on the stock. This represents a 16.0% upside from the current price of $3.88.

Stock Yards Bancorp (NASDAQ:SYBT) was downgraded by analysts at Stephens from an “overweight” rating to an “equal weight” rating. They now have a $76.00 price target on the stock, up previously from $70.00. This represents a 3.0% upside from the current price of $73.80.

TreeHouse Foods (NYSE:THS) was downgraded by analysts at Consumer Edge from an “overweight” rating to an “equal weight” rating.The current price is $31.91.

Turnstone Biologics (NASDAQ:TSBX) was downgraded by analysts at Bank of America Co. from a “neutral” rating to an “underperform” rating.The current price is $0.48.

VIEW MORE DOWNGRADES

5 Stocks Set To Soar From Trump (ad)

This Catalyst Hits Once Every 4 Years..

Every four years, on the day of the election, a catalyst is triggered.

Over the last 20 years, this catalyst has caused 1,500 stocks to rise an average of 3,700%… within 90 days.

And now, Tim Bohen is blowing the whole story wide open on Wednesday, November 20th at 8PM.

CLICK HERE FOR DETAILS ON YOUR FREE RSVP.

Analysts’ New Coverage

AbbVie (NYSE:ABBV) is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $205.00 price target on the stock. This represents a 23.3% upside from the current price of $166.29.

Amgen (NASDAQ:AMGN) is now covered by analysts at Wolfe Research. They set a “peer perform” rating on the stock.The current price is $281.30.

Biogen (NASDAQ:BIIB) is now covered by analysts at Wolfe Research. They set a “peer perform” rating on the stock.The current price is $161.07.

BioMarin Pharmaceutical (NASDAQ:BMRN) is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $95.00 price target on the stock. This represents a 48.6% upside from the current price of $63.91.

Bristol-Myers Squibb (NYSE:BMY) is now covered by analysts at Wolfe Research. They set a “peer perform” rating on the stock.The current price is $56.74.

CDW (NASDAQ:CDW) is now covered by analysts at Redburn Atlantic. They set a “buy” rating and a $230.00 price target on the stock. This represents a 28.7% upside from the current price of $178.70.

Chipotle Mexican Grill (NYSE:CMG) is now covered by analysts at Royal Bank of Canada. They set an “outperform” rating and a $70.00 price target on the stock. This represents a 18.9% upside from the current price of $58.88.

Core Scientific (NASDAQ:CORZ) is now covered by analysts at Roth Mkm. They set a “buy” rating and a $25.50 price target on the stock. This represents a 61.5% upside from the current price of $15.79.

Doximity (NASDAQ:DOCS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $58.00 price target on the stock. This represents a 17.9% upside from the current price of $49.18.

Everus (NYSE:ECG) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $71.00 price target on the stock. This represents a 26.0% upside from the current price of $56.33.

EMCOR Group (NYSE:EME) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $600.00 price target on the stock. This represents a 19.4% upside from the current price of $502.70.

First Advantage (NYSE:FA) is now covered by analysts at Royal Bank of Canada. They set an “outperform” rating and a $22.00 price target on the stock. This represents a 23.7% upside from the current price of $17.78.

Comfort Systems USA (NYSE:FIX) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $524.00 price target on the stock. This represents a 17.8% upside from the current price of $445.00.

Gilead Sciences (NASDAQ:GILD) is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $110.00 price target on the stock. This represents a 22.5% upside from the current price of $89.76.

Grail (NASDAQ:GRAL) is now covered by analysts at Wolfe Research. They set a “peer perform” rating on the stock.The current price is $14.70.

HealthEquity (NASDAQ:HQY) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $108.00 price target on the stock. This represents a 10.7% upside from the current price of $97.53.

Johnson & Johnson (NYSE:JNJ) is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $190.00 price target on the stock. This represents a 24.4% upside from the current price of $152.78.

Eli Lilly and Company (NYSE:LLY) is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $1,000.00 price target on the stock. This represents a 33.1% upside from the current price of $751.36.

Limbach (NASDAQ:LMB) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $108.00 price target on the stock. This represents a 21.3% upside from the current price of $89.03.

Merck & Co., Inc. (NYSE:MRK) is now covered by analysts at Wolfe Research. They set a “peer perform” rating on the stock.The current price is $96.26.

Moderna (NASDAQ:MRNA) is now covered by analysts at Wolfe Research. They set an “underperform” rating and a $40.00 price target on the stock. This represents a 8.7% upside from the current price of $36.80.

Mersana Therapeutics (NASDAQ:MRSN) is now covered by analysts at Citigroup Inc.. They set a “buy” rating and a $5.00 price target on the stock. This represents a 111.0% upside from the current price of $2.37.

Insight Enterprises (NASDAQ:NSIT) is now covered by analysts at Redburn Atlantic. They set a “buy” rating and a $220.00 price target on the stock. This represents a 44.5% upside from the current price of $152.25.

Pfizer (NYSE:PFE) is now covered by analysts at Wolfe Research. They set an “underperform” rating and a $25.00 price target on the stock. This represents a 0.3% downside from the current price of $25.08.

Regeneron Pharmaceuticals (NASDAQ:REGN) is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $1,150.00 price target on the stock. This represents a 51.5% upside from the current price of $758.91.

Starbucks (NASDAQ:SBUX) is now covered by analysts at Royal Bank of Canada. They set an “outperform” rating and a $115.00 price target on the stock. This represents a 16.0% upside from the current price of $99.12.

Simulations Plus (NASDAQ:SLP) is now covered by analysts at Stephens. They set an “overweight” rating and a $39.00 price target on the stock. This represents a 35.4% upside from the current price of $28.81.

Teladoc Health (NYSE:TDOC) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $14.00 price target on the stock. This represents a 58.2% upside from the current price of $8.85.

Veracyte (NASDAQ:VCYT) is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $50.00 price target on the stock. This represents a 40.1% upside from the current price of $35.70.

VIEW MORE NEW COVERAGE

Calendars from MarketBeat

U.S. Analyst Ratings

Corporate Buybacks

Cryptocurrencies

Dividend Declarations

Earnings Announcements

Earnings Conference Calls

Economic Reports

Gap Up/Down Stocks

Insider Trades

Initial Public Offerings (IPOs)

Most Active Stocks

Percentage Gainers/Decliners

Sector Performance

Short Interest

Stock Splits

Unusual Options Volume

Unusual Trading Volume

GET 30 DAYS OF MARKETBEAT ALL ACCESS FREE

Best-in-Class Portfolio Monitoring

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools

Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.